Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/13/2007 | US20070212334 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
09/13/2007 | US20070212333 Methods and compositions for the treatment of dystonia |
09/13/2007 | US20070212330 Nucleic Acid Molecules As Herpanase Potent Inhibitors, Compositions And Methods Of Use Thereof |
09/13/2007 | US20070212311 Recombinant Alkalinizing Bacteria |
09/13/2007 | US20070212301 Monkey Immunoglobulin Sequences |
09/13/2007 | DE202007003784U1 Vorrichtung zur Reinigung von Biomolekülen Apparatus for the purification of biomolecules |
09/13/2007 | DE102006011133A1 Chimäres Polypeptidmolekül The chimeric polypeptide molecule |
09/13/2007 | DE10037270B4 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
09/13/2007 | CA2646509A1 Compositions and methods for increasing plant tolerance to high population density |
09/13/2007 | CA2645134A1 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
09/13/2007 | CA2645045A1 Specific amplification of fetal dna sequences from a mixed, fetal-maternal source |
09/13/2007 | CA2644947A1 Methods for increasing shoot-to-root ratio, seed production and resistance to diseases |
09/13/2007 | CA2644474A1 Site-specific incorporation of amino acids into molecules |
09/13/2007 | CA2644255A1 Chimeric kunitz domains and their use |
09/13/2007 | CA2644170A1 Humanized anti-cd20 monoclonal antibody |
09/13/2007 | CA2644130A1 Polynucleotide encoding a maize herbicide resistance gene and methods for use |
09/13/2007 | CA2644127A1 Human interferon-gamma (infgamma) variants |
09/13/2007 | CA2643951A1 Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders |
09/13/2007 | CA2643364A1 Rifaximin anti-rectal dysfunction preparation |
09/13/2007 | CA2642654A1 Process for preparing human g-csf |
09/13/2007 | CA2638791A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof |
09/13/2007 | CA2638763A1 System for the expression of orthogonal translation components in eubacterial host cells |
09/13/2007 | CA2638739A1 Compositions related to the quantitative trait locus 6 (qtl6) in maize and methods of use |
09/13/2007 | CA2606130A1 Gene encoding glycogen synthesis initiator and use thereof |
09/12/2007 | EP1832663A2 Uses of DNA-PK |
09/12/2007 | EP1832662A2 DNA encoding chondroitin synthase from Pasteurella multocida and methods of use |
09/12/2007 | EP1832660A1 Method of screening antiobesity drug |
09/12/2007 | EP1832657A1 Methylation of plasmid vectors |
09/12/2007 | EP1832656A1 Method for isolating and using fungal hemolysin |
09/12/2007 | EP1832655A2 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
09/12/2007 | EP1832654A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
09/12/2007 | EP1832653A1 MN gene and protein |
09/12/2007 | EP1832652A2 Improved nucleic acid modifying enzymes |
09/12/2007 | EP1832651A1 A fast method of transforming competent cells |
09/12/2007 | EP1832605A1 Neural cell adhesion molecule (NCAM) binding antibodies |
09/12/2007 | EP1832603A2 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy |
09/12/2007 | EP1832599A2 Albumin fusion proteins |
09/12/2007 | EP1832567A2 Evolving new molecular function |
09/12/2007 | EP1832297A1 Anticoagulant agents useful in treatment of thrombosis |
09/12/2007 | EP1832292A1 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
09/12/2007 | EP1831693A2 Use of pta peptides for stratification of individuals having cancer |
09/12/2007 | EP1831688A1 Methods and compositions for treating epithelial cancers |
09/12/2007 | EP1831396A2 Control sequences responding to amp and uses thereof |
09/12/2007 | EP1831382A2 Method for reversing multiple resistance in animal cells |
09/12/2007 | EP1831381A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
09/12/2007 | EP1831380A2 Nucleic acid molecules encoding fatty acid desaturase genes from plants and methods of use |
09/12/2007 | EP1831379A2 Nucleotide sequences and polypeptides encoded thereby useful for enhancing plant drought tolerance |
09/12/2007 | EP1831378A2 Sugarcane plants with an increased storage carbohydrate content |
09/12/2007 | EP1831377A1 Method for producing polyunsaturated fatty acids in transgenic organisms |
09/12/2007 | EP1831376A1 Improved grain quality through altered expression of seed proteins |
09/12/2007 | EP1831375A1 Gene expression technique |
09/12/2007 | EP1831374A1 Multiple promoters and the use thereof for gene expression |
09/12/2007 | EP1831373A2 Recombinant production of serum albumin |
09/12/2007 | EP1831372A2 Neutralizing epitope-based growth enhancing vaccine |
09/12/2007 | EP1831371A2 Muteins of fibroblast growth factor 21 |
09/12/2007 | EP1831370A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
09/12/2007 | EP1831369A2 Rnai inhibition of serum amyloid a for treatment of glaucoma |
09/12/2007 | EP1831368A2 Cancer treatment |
09/12/2007 | EP1831367A2 Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion |
09/12/2007 | EP1831366A2 Chinese hamster apoptosis-related genes |
09/12/2007 | EP1831365A2 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
09/12/2007 | EP1831364A1 Compositions and methods for expression and purification of fatty acid amide hydrolase |
09/12/2007 | EP1831362A2 Acid fungal proteases |
09/12/2007 | EP1831360A2 Alpha-amylase variants |
09/12/2007 | EP1831359A1 Nucleic acid molecules encoding kcs-like polypeptides and methods of use |
09/12/2007 | EP1831358A2 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
09/12/2007 | EP1831347A1 INDUSTRIAL PRODUCING STRAIN OF THE FUNGUS CLAVICEPS PURPUREA (Fr.) Tul. |
09/12/2007 | EP1831256A1 Immunoglobulins comprising predominantly a galglcnacman5glcnac2 glycoform |
09/12/2007 | EP1831252A1 Glp-1 analog fusion protein formulations |
09/12/2007 | EP1831249A2 Novel genes involved in gluconeogenesis |
09/12/2007 | EP1830877A2 Recombinant bcg strains with attenuated immunosuppresive properties |
09/12/2007 | EP1830872A2 Fusion proteins |
09/12/2007 | EP1830866A2 METHODS AND COMPOSITIONS CONCERNING siRNA'S AS MEDIATORS OF RNA INTERFERENCE |
09/12/2007 | EP1830864A2 E1-minus adenoviruses and use thereof |
09/12/2007 | EP1689447A4 Gene transfer for regulating smooth muscle tone |
09/12/2007 | EP1634950B1 Method of preparing gene expression profile |
09/12/2007 | EP1589807A4 Transgenic pineapple plants with modified carotenoid levels and methods of their production |
09/12/2007 | EP1583839A4 METHODS OF CAPTURING, DETECTING AND QUANTIFYING RNA:DNA HYBRIDS AND A MODIFIED RNase H USEFUL THEREIN |
09/12/2007 | EP1532849B1 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
09/12/2007 | EP1527091B1 Corn root preferential promoters and uses thereof |
09/12/2007 | EP1492872B1 Expression of phospholipid:diacylglycerine acyltransferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids |
09/12/2007 | EP1481053B1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
09/12/2007 | EP1465481A4 Knockout swine and methods for making the same |
09/12/2007 | EP1463836A4 Vector mediated organelle transfection |
09/12/2007 | EP1453978B9 Analysis and detection of multiple target sequences using circular probes |
09/12/2007 | EP1412753B1 Biochip and the production method thereof |
09/12/2007 | EP1407013B1 Mutations in ion channels |
09/12/2007 | EP1391510B1 Method of constructing host and process for producing foreign protein |
09/12/2007 | EP1373570B1 Improved in vitro synthesis system |
09/12/2007 | EP1354945B1 Method of identifying within a rodent a dna encoding physiologically active polypeptide |
09/12/2007 | EP1353179B1 Fluorescent analysis element with the use of metallic nanowell and process for producing the same |
09/12/2007 | EP1320542B9 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
09/12/2007 | EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
09/12/2007 | EP1303617B1 Mutant muscle-specific enhancers |
09/12/2007 | EP1303589B1 Pre-adipose cell lines |
09/12/2007 | EP1299541B1 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
09/12/2007 | EP1276885B1 Trophic conversion of obligate phototrophic algae through metabolic engineering |
09/12/2007 | EP1246911B1 Method for detecting and characterising active agents against plant pathogens |
09/12/2007 | EP1230347B1 Method for the preparation of purified hcv rna by exosome separation |
09/12/2007 | EP1224266B1 Lysosomal targeting pathway enzymes |